First Case of TAP1 Deficiency with EBV B-Cell Lymphoma Treated with Cellular Immunotherapy
J Clin Immunol. 2026 Apr 9. doi: 10.1007/s10875-026-01997-0. Online ahead of print. NO ABSTRACT PMID:41954665 | DOI:10.1007/s10875-026-01997-0
Journal of Clinical Immunology
Characteristics of Mycobacterial, COVID-19, and Talaromyces Marneffei Infections in Patients with IL12RB1 and IFNGR1 Mutations in Western China
J Clin Immunol. 2026 Apr 10. doi: 10.1007/s10875-026-01991-6. Online ahead of print. NO ABSTRACT PMID:41957131 | DOI:10.1007/s10875-026-01991-6
A Unique NCF2 Mutation in Chronic Granulomatous Disease: Clinical and Computational Insights into NADPH Oxidase Dysfunction
J Clin Immunol. 2026 Apr 6;46(1):39. doi: 10.1007/s10875-026-02014-0. NO ABSTRACT PMID:41941091 | DOI:10.1007/s10875-026-02014-0
Anifrolumab to Treat Severe Hepatic Involvement in a De Novo IFIH1 Mutation
J Clin Immunol. 2026 Apr 6;46(1):41. doi: 10.1007/s10875-026-01981-8. NO ABSTRACT PMID:41941034 | DOI:10.1007/s10875-026-01981-8
Expanding the Spectrum of Src-Family Kinase-Related Autoinflammatory Diseases: Monogenic Vasculitis Caused By Germline Pathogenic Variants in HCK and FGR
J Clin Immunol. 2026 Apr 1. doi: 10.1007/s10875-026-01998-z. Online ahead of print. NO ABSTRACT PMID:41920357 | DOI:10.1007/s10875-026-01998-z
Unclassified Inborn Errors of Immunity Patients without any Pathogenic Variant in Targeted Next-Generation Sequencing: Long-Term Follow-up and Whole Exome Sequencing Results
J Clin Immunol. 2026 Mar 31. doi: 10.1007/s10875-026-02007-z. Online ahead of print. NO ABSTRACT PMID:41917218 | DOI:10.1007/s10875-026-02007-z
Continuous Infusion of the CXCR4 Antagonist Plerixafor for WHIM Syndrome
J Clin Immunol. 2026 Mar 29. doi: 10.1007/s10875-026-02010-4. Online ahead of print. NO ABSTRACT PMID:41904735 | DOI:10.1007/s10875-026-02010-4
Optical Genome Mapping for the Identification of Complex Structural Variants in Hereditary Angioedema
J Clin Immunol. 2026 Mar 28. doi: 10.1007/s10875-026-02015-z. Online ahead of print. NO ABSTRACT PMID:41896320 | DOI:10.1007/s10875-026-02015-z
A Novel Phosphoglucomutase-3 Gene Variant Causing Milder Phenotype in Two Families
J Clin Immunol. 2026 Mar 29. doi: 10.1007/s10875-026-02012-2. Online ahead of print. NO ABSTRACT PMID:41904308 | DOI:10.1007/s10875-026-02012-2
Allogeneic Hematopoietic Cell Transplantation for Congenital Athymia: A Nationwide Retrospective Study in Japan
J Clin Immunol. 2026 Mar 28. doi: 10.1007/s10875-026-02008-y. Online ahead of print. ABSTRACT PURPOSE: Congenital athymia is a life-threatening condition characterized by thymic absence and profound T-cell immunodeficiency. Thymus implantation is the definitive treatment, but its availability is limited. This study aimed to evaluate the outcomes of hematopoietic cell transplantation (HCT) as an alternative therapy. … Read more